Amit Munshi's Net Worth

$26.5 Million

Estimate Recalculated Jul 15, 2025 03:16PM EST

Who is Amit Munshi

Amit Munshi has an estimated net worth of $26.5 Million. This is based on reported shares across multiple companies, which include ARENA PHARMACEUTICALS INC, Pulmatrix, Inc., Social Capital Suvretta Holdings Corp. IV, Galecto, Inc., Zura Bio Ltd, and EPIRUS Biopharmaceuticals, Inc..

SEC CIK

Amit Munshi's CIK is 0001612551

Past Insider Trading and Trends

2020 was Amit Munshi's most active year for acquiring shares with 15 total transactions. Amit Munshi's most active month to acquire stocks was the month of May. 2020 was Amit Munshi's most active year for disposing of shares, totalling 25 transactions. Amit Munshi's most active month to dispose stocks was the month of February. 2020 saw Amit Munshi paying a total of $4,557,665.74 for 722,524 shares, this is the most they've acquired in one year. In 2021 Amit Munshi cashed out on 246,800 shares for a total of $9,797,604.33, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ARENA PHARMACEUTICALS INC

President and CEO
Updated Mar 11, 2022
Form 4
-100.00%
-1.40M
$98.51
Mar 11, 2022
Disposition
Mar 08 - Mar 11
Form 4
217.06%
85.85K
Jan 05, 2022
125.40K
Grant
Jan 03
Form 4
2.59%
1.00K
$48.19
$48.19K
Aug 17, 2021
39.55K
Purchase
Aug 16
Form 4
2.66%
1.00K
$50.41
$50.41K
Aug 13, 2021
38.55K
Purchase
Aug 12
Form 4
2.74%
1.00K
$52.92
$52.92K
Aug 11, 2021
37.55K
Purchase
Aug 10
Form 4
3,081.29%
238.80K
Mar 03, 2021
246.55K
Grant
Mar 01
Form 4
-40.67%
-100.00K
$47.85
-$6.47M
Jan 20, 2021
145.89K
Sale
ScheduledJan 15 - Jan 19
Form 4
-65.75%
-14.88K
$75.12
-$1.12M
Jan 14, 2021
7.75K
Sale
ScheduledJan 12
Form 4
-27.36%
-8.52K
$77.59
-$661.30K
Jan 11, 2021
22.63K
Options
Jan 07
Form 4
-45.68%
-6.52K
$70.00
-$456.20K
Dec 09, 2020
7.75K
Sale
ScheduledDec 08
Form 4
-12.10%
-5.18K
$65.50
-$339.49K
Nov 30, 2020
37.67K
Options
Nov 25
Form 4
-28.91%
-100.00K
$42.78
-$5.46M
Aug 31, 2020
245.89K
Sale
ScheduledAug 28 - Aug 31
Form 4
-19.89%
-100.00K
$40.88
-$5.18M
Jun 04, 2020
402.75K
Sale
ScheduledJun 02 - Jun 03
Form 4
-40.86%
-84.80K
$35.44
-$3.53M
May 22, 2020
122.75K
Sale
ScheduledMay 21 - May 22
Form 4
270.00K
Mar 03, 2020
270.00K
Grant
Mar 01
Form 4
-6.82%
-15.20K
$34.80
-$614.08K
Feb 14, 2020
207.55K
Sale
ScheduledFeb 13
Form 4
-47.91%
-7.13K
$50.00
-$356.45K
Feb 07, 2020
7.75K
Sale
ScheduledFeb 05
Form 4
-8.38%
-4.57K
$47.32
-$216.30K
Oct 16, 2019
49.98K
Options
Oct 14
Form 4
308.40K
Jan 08, 2019
308.40K
Grant
Jan 04
Form 4
310.00K
Jan 22, 2018
310.00K
Grant
Jan 19
Form 4
48.19%
25.00K
$1.19
$29.75K
May 15, 2017
76.88K
Purchase
May 12
Form 4
4,050.00%
50.63K
$1.41
$71.28K
Apr 27, 2017
51.88K
Purchase
Mar 31 - Apr 26
Form 4
2.15M
$1.31
$1.64K
Feb 14, 2017
2.15M
Acq/Dis
Sep 30 - Feb 13
Form 4
3.80M
May 11, 2016
3.80M
Grant
May 11
Form 3
May 11, 2016
Showing 25 results

Pulmatrix, Inc.

Investor
Updated Feb 01, 2021
Form 4
15.00K
Feb 01, 2021
15.00K
Grant
Jan 28
Form 4
10.00K
Apr 03, 2020
10.00K
Grant
Apr 02
Form 4
15.00K
Jan 13, 2020
15.00K
Grant
Jan 09
Form 4
15.00K
May 20, 2019
15.00K
Grant
May 16
Form 4
124.00K
Jun 06, 2018
124.00K
Grant
Jun 05
Form 4
8.80K
Jun 15, 2017
8.80K
Grant
Jun 13
Form 3
Jun 15, 2017
Showing 7 results

Social Capital Suvretta Holdings Corp. IV

Investor
Updated Jun 29, 2021
Form 3
Jun 29, 2021
Showing 1 results

Galecto, Inc.

Investor
Updated Jun 21, 2024
Form 4
18.00K
Jun 21, 2024
18.00K
Grant
Jun 20
Form 4
18.00K
Jun 15, 2023
18.00K
Grant
Jun 14
Form 4
18.00K
Jun 15, 2022
18.00K
Grant
Jun 14
Form 4
113.98K
$27.11
$49.99K
Nov 04, 2020
113.98K
Options
Jun 24 - Nov 02
Form 3
Oct 28, 2020
Showing 5 results

Zura Bio Ltd

Investor
Updated Sep 06, 2024
Form 4/A
25.86%
159.74K
$3.13
$500.00K
Sep 06, 2024
777.38K
Grant
Apr 22
Form 4
25.86%
159.74K
$3.13
$500.00K
Apr 24, 2024
777.38K
Purchase
Apr 22
Form 4
23.53%
117.65K
$4.25
$500.00K
Jun 05, 2023
617.64K
Purchase
Jun 05
Form 4
1.13M
Jun 02, 2023
1.13M
Grant
Jun 01
Form 3
Mar 21, 2023
499.99K
Showing 5 results

EPIRUS Biopharmaceuticals, Inc.

Chief Executive Officer
Updated Mar 01, 2016
Form 4
-2.04%
-4.30K
$2.80
-$12.05K
Mar 01, 2016
206.74K
Options
Feb 27
Form 4
5.11%
8.27K
$2.80
$23.16K
Dec 17, 2015
169.98K
Purchase
Dec 16
Form 4
5.25%
8.07K
$2.87
$23.16K
Dec 16, 2015
161.71K
Purchase
Dec 15
Form 4
9.39%
13.19K
$4.07
$53.68K
Dec 10, 2015
153.64K
Purchase
Dec 09
Form 4
199.54K
Nov 03, 2015
199.54K
Grant
Nov 02
Form 4
7.67%
10.00K
$6.19
$61.90K
Sep 22, 2015
140.45K
Purchase
Sep 21
Form 4
8.30%
10.00K
$5.99
$59.86K
Sep 21, 2015
130.45K
Purchase
Sep 18
Form 4
$1.00
$51.20K
Jul 06, 2015
197.35K
Options
Jul 02
Form 4
342.29K
Mar 02, 2015
342.29K
Grant
Feb 27
Form 4
530.04K
Jul 17, 2014
530.04K
Grant
Jul 15
Form 3
Jul 15, 2014
Showing 11 results

Inhibikase Therapeutics, Inc.

Investor
Updated Oct 23, 2024
Form 4
425.00K
$1.37
$500.05K
Oct 23, 2024
425.00K
Purchase
Oct 21
Form 3
Oct 23, 2024
Showing 2 results